{"id":"W2043627490","doi":"10.1212/01.wnl.0000042321.94839.78","title":"Phase I study of thalidomide for the treatment of plexiform neurofibroma in neurofibromatosis 1","year":2003,"lang":"en","type":"article","venue":"Neurology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Health Canada; Celgene","keywords":"Plexiform neurofibroma; Neurofibromatosis; Rash; Somnolence; Medicine; Neurofibroma; Adverse effect; Thalidomide; Peripheral neuropathy; Dermatology; Gastroenterology; Surgery; Internal medicine; Pathology; Endocrinology; Multiple myeloma","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001101093,0.001434864,0.001515128,0.0004027278,0.0004199757,0.000797118,0.0009572475,0.001262769,0.002276704],"category_scores_gemma":[0.001282343,0.0005071394,0.0009522557,0.0002775833,0.0007455369,0.0006462178,0.0002001157,0.002101054,0.0005358855],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007848421,"about_ca_system_score_gemma":0.001003641,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001642634,"about_ca_topic_score_gemma":0.003002016,"domain_scores_codex":[0.9996971,0.0001649467,0.00001389392,0.0000366425,0.00002572699,0.0000616526],"domain_scores_gemma":[0.9994583,0.0001407911,0.00008730106,0.00003598732,0.000040489,0.0002370972],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7129409,0.09066947,0.004500498,0.001382296,0.001869036,0.0009497694,0.0007940177,0.003515067,0.05381484,0.0006535421,0.004964922,0.1239456],"study_design_scores_gemma":[0.6602479,0.3280382,0.005084487,0.00004143365,0.0002944524,0.0003860025,0.00007329992,0.001077763,0.00273396,0.0002081768,0.001786058,0.00002830616],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9924538,0.00272096,0.0006450254,0.0004100668,0.0001293607,0.001755929,0.0003779341,0.00007719469,0.001429936],"genre_scores_gemma":[0.9912872,0.002876836,0.0009577808,0.0005223805,0.0001366478,0.001902374,0.0008625783,0.00001862639,0.001435821],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002276704,"threshold_uncertainty_score":0.007616401,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04463292221864062,"score_gpt":0.3210466027307381,"score_spread":0.2764136805120975,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}